Dergiler / Turkish Journal of Medical Sciences / 2020 / Cilt: 50 - Sayı: 8

Serum paraoxonase 1 and 3 activities in benign and malignant diseases of the prostate and changes in levels following robotic-assisted laparoscopic radical prostatectomy

Sayfa
1872–1878
Yayın Tarihi
2022-11-06
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Surgical excision of malignant tissue in PCa causes a decrease in oxidative stress.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Background/aim: This study aimed to examine serum paraoxonase 1 and 3 (PON1 and PON3) activities in benign and malignant diseases of the prostate, to determine lipid profile and malondialdehyde (MDA) levels, and to investigate changes in levels following robotic-assisted laparoscopic radical prostatectomy (RALRP).
📊
Temel Bulgular & Veri:Materials and methods: A total of 137 patients, including a control group, were enrolled in the study and assigned into four groups.
💡
Sonuç & Katkı:Surgical excision of malignant tissue in PCa causes a decrease in oxidative stress.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Background/aim: This study aimed to examine serum paraoxonase 1 and 3 (PON1 and PON3) activities in benign and malignant diseases of the prostate, to determine lipid profile and malondialdehyde (MDA) levels, and to investigate changes in levels following robotic-assisted laparoscopic radical prostatectomy (RALRP). Materials and methods: A total of 137 patients, including a control group, were enrolled in the study and assigned into four groups. Group 1 (n = 33) consisted of patients previously undergoing RALRP with no recurrence, group 2 (n = 36) consisted of patients diagnosed with prostate cancer (PCa) and undergoing RALRP, and group 3 (n = 34) consisted of patients diagnosed with benign prostatic hyperplasia. The control group (n = 34) consisted of healthy individuals. Serum low-density lipoprotein (LDL), high-density lipoprotein (HDL), triglyceride, cholesterol, prostate-specific antigen (PSA), PON1, PON3, and MDA values were measured. In addition, group 2 MDA, PON1, PON3, and PON1/HDL levels were investigated preoperatively and at the first month postoperatively. Results: Significant changes were found in PON1, PON3, and MDA levels. PON1 and PON3 levels decreased significantly in patients with PCa, while MDA levels increased. PON1 and PON3 increased postoperatively in the PCa group, while MDA decreased. BPH group PON1, PON3, and MDA levels were higher than those of the control group. Conclusion: An increase in free oxygen radicals in the body or a decrease in endogenous antioxidant enzyme levels can result in malignant and benign diseases of the prostate. Surgical excision of malignant tissue in PCa causes a decrease in oxidative stress.

🔖

Bu Makaleye Atıf Yap

BEDİR, F., KOCATÜRK, H., ALTAY, M. S., ŞEBİN, E., BEDİR, B. (2022). Serum paraoxonase 1 and 3 activities in benign and malignant diseases of the prostate and changes in levels following robotic-assisted laparoscopic radical prostatectomy. Turkish Journal of Medical Sciences, Cilt: 50 - Sayı: 8, 1872–1878. https://ajindex.com/articles/610026

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (3)

  1. Şenel C, Tuncel A. Prostat Kanseri Belirteçleri. Türkiye Klinikleri Urology-Special Topics, 2017;10 (2): 93-101 (in Turkish)
  2. Rawla P. Epidemiology of Prostate Cancer. World Journal of Oncology. 2019; 10 (2): 63-89. doi:10.14740/wjon1191 3. De Marzo AM, Coffey DS, Nelson WG. New concepts in tissue specificity for prostate cancer and benign prostatic hyperplasia. Urology. 1999; 53 (3): 29-40
  3. Zhang S, Li LH, Qiao HM, Yang X, Chen L et al. Regulation of the antioxidant response by MyoD transcriptional coactivator in castration-resistant prostate cancer cells. Urology. 2019; 123 (296): (9-18). doi:10.1016/j.urology.2018.04.028 5. Kaya E, Ozgok Y, Zor M, Eken A, Bedir S et al. Oxidative stress parameters in patients with prostate cancer, benign prostatic hyperplasia and asymptomatic inflammatory prostatitis: A prospective controlled study. Advances In Clinical And Experimental Medicine 2017; 26 (7): 1095-1099. doi:10.17219/ acem/66837 6. Babior BM. Phagocytes and oxidative stress. American Journal Medicine 2000; 109 (1): 33-44. doi:10.1016/s0002- 9343(00)00481-2 7. Del Rio D, Stewart AJ, Pellegrini N. A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress. Nutrition Metabolism Cardiovascular Diseases 2005; 15 (4): 316-328. doi:10.1016/j.numecd.2005.05.003 8. Cobanoglu U, Demir H, Duran M, Şehitogullari A, Mergan D et al. Erythrocyte catalase and carbonic anhydrase activities in lung cancer. Asian Pacific Journal of Cancer Prevention 2010; 11 (5): 1377-1382 9. Ng CJ, Shih DM, Hama SY, Villa N, Navab M et al. The paraoxonase gene family and atherosclerosis. Free radical Biology & Medicine. 2005; 38 (2): 153-163. doi:10.1016/j. freeradbiomed.2004.09.035 10. Reddy ST, Wadleigh DJ, Grijalva V, Ng C, Hama S et al. Human paraoxonase-3 is an HDL-associated enzyme with biological activity similar to paraoxonase-1 protein but is not regulated by oxidized lipids. Arteriosclerosis, Thrombosis, and Vascular Biology 2001; 21 (4): 542-547. doi:10.1161/01.atv.21.4.542 11. Sinha K, Das J, Pal PB, Sil PC. Oxidative stress: the mitochondria-dependent and mitochondria-independent pathways of apoptosis. Archives of Toxicology 2013; 87 (7): 1157-1180. doi:10.1007/s00204-013-1034-4 12. Khandrika L, Kumar B, Koul S, Maroni P, Koul HK. Oxidative stress in prostate cancer. Cancer Letters 2009; 282 (2): 125- 1236. doi:10.1016/j.canlet.2008.12.011 13. Precourt LP, Amre D, Denis MC, Lavoie JC, Delvin E et al. The three-gene parao